QURATULAIN AGHA: Open Payments
NPI 1093155590 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,483 in 155 payments from 14 companies in 2025. Trend: 2023 $2,378 · 2024 $2,044 · 2025 $2,483
Food & beverage: $2,373Education: $109
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $430 |
| Axsome Therapeutics, Inc. | 24 | $428 |
| Corium, LLC | 24 | $381 |
| Otsuka America Pharmaceutical, Inc. | 19 | $299 |
| ABBVIE INC. | 16 | $201 |
| Teva Pharmaceuticals USA, Inc. | 6 | $198 |
| Bausch Health US, LLC | 15 | $152 |
| Alkermes, Inc. | 8 | $140 |
| Janssen Pharmaceuticals, Inc | 4 | $77 |
| Collegium Pharmaceutical, Inc. | 4 | $63 |
Products named: CAPLYTA, Azstarys, REXULTI, Auvelity, Sunosi, VRAYLAR, APLENZIN, ARISTADA.
Industry payments across AL — which companies pay providers there.
